ArticleCureus2024

Tofacitinib in Patients Hospitalized With Moderate and Severe COVID-19: Not Just Another Kinase Inhibitor.

Tharanath Shankar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.